Cellular Therapy

Conference Coverage

Tocilizumab shows promise for GVHD prevention

ORLANDO – The interleuken-6 receptor blocker tocilizumab showed promising activity for preventing graft-versus-host disease when added to standard...

From the Journals

MDS gene mutations predict response to HSCT

Genetic mutations in blood samples may predict outcomes and guide treatment for patients of all ages who have myelodysplastic syndrome and are...

Pages